GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2019. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $40,147,000 | +93.2% | 589,525 | -9.3% | 0.02% | +100.0% |
| Q2 2022 | $20,777,000 | +128.9% | 650,269 | +130.3% | 0.01% | +166.7% |
| Q1 2022 | $9,078,000 | +22.0% | 282,374 | +0.5% | 0.00% | +50.0% |
| Q4 2021 | $7,441,000 | +34.3% | 280,864 | +42.0% | 0.00% | 0.0% |
| Q3 2021 | $5,542,000 | -57.4% | 197,739 | -46.8% | 0.00% | -50.0% |
| Q2 2021 | $13,024,000 | -42.2% | 371,913 | -32.7% | 0.00% | -42.9% |
| Q1 2021 | $22,528,000 | -24.6% | 552,834 | -19.8% | 0.01% | -30.0% |
| Q4 2020 | $29,863,000 | +42.4% | 689,498 | +81.3% | 0.01% | +25.0% |
| Q3 2020 | $20,966,000 | +67.7% | 380,209 | +92.0% | 0.01% | +60.0% |
| Q2 2020 | $12,499,000 | -11.5% | 197,985 | -28.4% | 0.01% | -28.6% |
| Q1 2020 | $14,120,000 | -31.2% | 276,362 | +7.0% | 0.01% | -12.5% |
| Q4 2019 | $20,531,000 | -14.6% | 258,285 | -47.9% | 0.01% | -20.0% |
| Q3 2019 | $24,047,000 | +108.6% | 495,605 | +126.1% | 0.01% | +100.0% |
| Q2 2019 | $11,530,000 | – | 219,203 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fernwood Investment Management, LLC | 355,509 | $17,171,000 | 9.58% |
| Perceptive Advisors | 4,989,066 | $240,971,000 | 6.75% |
| GREAT POINT PARTNERS LLC | 736,631 | $35,579,000,000 | 5.28% |
| Casdin Capital, LLC | 600,000 | $28,980,000 | 5.10% |
| Avoro Capital Advisors LLC | 1,765,548 | $85,276,000 | 4.07% |
| Iguana Healthcare Management, LLC | 115,000 | $5,555,000 | 3.65% |
| Camber Capital Management LP | 1,200,000 | $57,960,000 | 2.85% |
| NEXTHERA CAPITAL LP | 315,147 | $15,222,000 | 2.51% |
| RTW INVESTMENTS, LP | 456,921 | $22,069,000 | 2.10% |
| EMORY UNIVERSITY | 41,610 | $2,010,000 | 1.44% |